Quest Diagnostics (DGX) released earnings for its third quarter that increased compared to the same period last year.
The company said its bottom line came in at $172 million, or $1.28 per share. This was up from $161 million, or $1.20 per share, in last year's third quarter.
The company said revenue for the quarter fell 1.1% to $1.88 billion. This was down from $1.90 billion last year.
Quest Diagnostics earnings at a glance:
-Earnings (Q3): $172 Mln. vs. $161 Mln. last year.
-Earnings Growth (Y-o-Y): 6.8%
-EPS (Q3): $1.28 vs. $1.20 last year.
-EPS Growth (Y-o-Y): 6.7%
-Revenue (Q3): $1.88 Bln vs. $1.90 Bln last year.
-Revenue Change (Y-o-Y): -1.1%
-Guidance:
Full year EPS guidance: $4.75 - $4.80
Full year revenue guidance: $7.49 Bln
For comments and feedback contact: editorial@rttnews.com